THE IMPORTANCE OF VOCAL CORD MOBILITY IN T2 LARYNGEAL-CANCER

被引:20
作者
WIGGENRAAD, RG
TERHAARD, CH
HORDIJK, GJ
RAVASZ, LA
机构
[1] STATE UNIV UTRECHT HOSP,DEPT RADIOTHERAPY,3511 GV UTRECHT,NETHERLANDS
[2] STATE UNIV UTRECHT HOSP,DEPT OTORHINOLARYNGOL,3511 GV UTRECHT,NETHERLANDS
关键词
Prognostic factor; T[!sub]2[!/sub] laryngeal cancer; Vocal cord mobility;
D O I
10.1016/0167-8140(90)90112-A
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In a retrospective study 75 patients with T2 laryngeal cancer treated from 1981 through 1985 were analysed. Of this group 71 patients had a full course of radiotherapy as primary therapy. All 71 patients were given 70 Gy/7 weeks on the primary and 50 Gy/5 weeks on the neck, 2 Gy per fraction. Various prognostic factors for local control and survival were studied. In our patient group we found vocal cord mobility to be an important prognostic factor for ultimate local control and survival. Patients with impaired cord mobility had a significantly worse ultimate local control (76%) than patients with normal cord mobility (98%) and a significantly worse corrected actuarial survival. It is concluded that impaired cord mobility means more advanced disease. Future studies will have to answer the question how to improve the local control rate in patients with impaired cord mobility, for example, by incorporating laryngectomy earlier in the treatment program of those patients who can not be cured by radiotherapy alone or by using innovative radiotherapy protocols. © 1990.
引用
收藏
页码:321 / 327
页数:7
相关论文
共 15 条
[1]   T2 GLOTTIC CANCER - AN ANALYSIS OF DOSE-TIME-VOLUME FACTORS [J].
HARWOOD, AR ;
BEALE, FA ;
CUMMINGS, BJ ;
KEANE, TJ ;
RIDER, WD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1981, 7 (11) :1501-1505
[2]  
HARWOOD AR, 1980, CANCER, V45, P991, DOI 10.1002/1097-0142(19800301)45:5<991::AID-CNCR2820450526>3.0.CO
[3]  
2-D
[4]   ANALYSIS OF FAILURES IN EARLY VOCAL-CORD CANCER [J].
HORIOT, JC ;
BALLANTYNE, AJ ;
FLETCHER, GH ;
LINDBERG, RD .
RADIOLOGY, 1972, 103 (03) :663-+
[5]  
KAPLAN MJ, 1983, LARYNGOSCOPE, V93, P725
[6]   HETEROGENEITY OF STAGE-II GLOTTIC CARCINOMA AND ITS THERAPEUTIC IMPLICATIONS [J].
KARIM, ABMF ;
KRALENDONK, JH ;
YAP, LY ;
NJO, KH ;
TIERIE, AH ;
TIWARI, RM ;
SNOW, GB ;
GERRITSEN, GJ ;
HASMAN, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1987, 13 (03) :313-317
[7]  
KARIM ABMF, 1983, CANCER, V51, P47, DOI 10.1002/1097-0142(19830101)51:1<47::AID-CNCR2820510112>3.0.CO
[8]  
2-1
[9]  
KUN LE, 1978, RADIOL CLIN, V47, P215
[10]  
MARKS JE, 1987, PRINCIPLES PRACTICE, P598